JRS JRS
Company Profile ↓Company Overview
JRS (JRS) is a publicly traded company listed on with a market capitalization of $212.07M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Trades at an undemanding P/E of 8.3.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $-4.05M (-115.9% YoY); net profit $-4.31M.
- Trailing 12 Months Year-on-year growth — revenue -115.9%, earnings -117.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | -115.85% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -117.04% |
Stock Price Performance
| 1 Year: | -1.62% |
| 6 Months: | -4.95% |
| 3 Months: | -13.39% |
| 1 Month: | -1.87% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- Death Cross2d ago
- RSI (14)45.32 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | -122.86M | 40.98M | 25.52M | -4.05M |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 299.01K | 281.23K | 219.91K | 266.14K |
| Operating Income | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | - | 3.02M | 5.52M | 5.84M | 5.15M |
| Pretax Income | - | -123.16M | 40.70M | 25.30M | -4.31M |
| Tax Provision | - | - | - | - | - |
| Net Income | - | -123.16M | 40.70M | 25.30M | -4.31M |
| Diluted EPS | 4.35 | -4.27 | 1.40 | 0.88 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 340.89M | 357.04M | 380.91M | 345.12M |
| Current Assets | - | - | - | - | - |
| Cash & Equivalents | - | 0 | 0 | 0 | 0 |
| Inventory | - | - | - | - | - |
| Receivables | - | 1.92M | 2.02M | 1.59M | 1.50M |
| Total Liabilities | - | 106.39M | 101.49M | 119.71M | 107.88M |
| Current Liabilities | - | - | - | - | - |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 104.40M | 98.50M | 116.82M | 107.02M |
| Total Equity | - | 234.50M | 255.55M | 261.20M | 237.25M |
| Shares Outstanding | - | 28.89M | 28.89M | 28.89M | 28.89M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 62.70M | 24.56M | 2.30M | 30.51M |
| Investing Cash Flow | - | - | - | - | - |
| Financing Cash Flow | - | -62.70M | -24.56M | -2.30M | -30.51M |
| Capital Expenditure | - | - | - | - | - |
| Free Cash Flow | - | 62.70M | 24.56M | 2.30M | 30.51M |
| Net Change in Cash | - | 0 | 0 | 0 | 0 |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | 100.2% | 99.3% | 99.1% | 106.6% |
| ROE % | - | -52.5% | 15.9% | 9.7% | -1.8% |
| ROCE % | - | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for JRS
(JRS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxNUkgxUGQzaWZURHB5aGpjOUNfLVdaNklKOFo2cnl3VmxaZXk1TndFb3Azd2p4YkN5UzJhdldjVFI2QUVVM25NOERsMUVZTm1EYXBwMHREd3IzajRLZEY4LXdHZ01xVUNiUlN4R1ZmQW5EVWVqbDVQSW45aFhhY1VLZ0FhdFIyYWl1aHhTWH…
JRS: A Dividend Cut Would Improve The Appeal (NYSE:JRS) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxOV2V2TVJRazFxZThQd1ZmRDJYYlNhZWJ3b3B2QlRfeHdrcUVxOTJSRmpub1VnVWRRdUxmTjB4ODRFNi1PZy1nSzI2VHBVVGEtb3VHWVpOcHo0RjJkOENEdXZIU0xIeVh2U0J3dVFaVUJMV2FXREZoNUlnVmR1MmJiRk1PQkpOSzk4N2tCTw…
Inside the Collapse of a MAGA Marketplace Backed by Trump Jr. - WSJ
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxOUE1iMlIzTzVsV0VRUnM3T19tTjQyUGpWTTA1OVh3bThueldnR185U1V0RU80U2VxQWFyVmNxOWdkSEFCZER4WXlzNGhCVTBIR3J1TlNxcGVKSmZMWjlJbmNJWFo4bTZ5NGpTcm9SOTBKVWctNXRRNDMzWGNVWlBFNWF6dVVESXFreWQ5OE…
Nuveen Real Estate Income Fund (JRS) Edges Higher as Yield Appeal Holds Steady - Smart Money Flow Stocks - dars.gov.et
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxNVmJYV3J3bUd1bGwxaHJvcFR4NEJKaFgtTExHckNEajNuZWVyTE9fZXhmTFk2b3pXN1FWRU9wLWRkVHEtTUw3TW1ZUWg2eHlKNXdlcjB1NE9vaFlNS3NFU3QyRmRLTUgwV3BBY1ZvTDFYRzJKNi1sYXRqbmdPRHJ1X294Y2dTaTJZMFpHS0…
Companies see boost from Trump admin after adding Don Jr. to their board - Citizens for Responsibility and Ethics in Washington
<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxOSGw0WUdBaTNZeFJER0h2RUtfNXotUzF0NU1NOElQcFAzZ1d1SEc5bk9Bb09uS1I1NGxOczdlMnFhTG1Kb1JtOGdOcms2MmxmcVFfRG1LTWlQZW5iZFpZSmlENDM0eUt1Y2JBN0FzaUc0YUF4M2NwWGx0cWZEbTVqSVhKOURXS3ZET1ktYl…
Boxing News: Vito Mielnicki Jr's Stock Rises After Dominant Win Over Austin “Ammo” Williams » October 17, 2026 - FightNews
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPd29nempNTFdWMUp4UTFremNxWndzbTlZVF9tc3NtUW9mTHVfSEJIcC1EYWNuc0pGcVJuZmFuSGFVQ1RyWVJqblVzWjRWSEZuN1pYVWtCd3BjalBPYnNvRWtWNWU2aEhvbjh5Y3l0N2x3Qm1LSGRCSGwwdjBGY2g4NGJIWnZtcGVaeEFHOF…
JRS — Frequently Asked Questions
What is the current share price of JRS?
As of 2026-10-23 16:27 PDT, JRS trades at $7.34 on NASDAQ/NYSE. Its 52-week range is $6.85 to $8.66.
What is the market capitalisation of JRS?
JRS has a market capitalisation of $212.07M on NASDAQ/NYSE.
What is the P/E ratio of JRS?
JRS trades at a trailing price-to-earnings (P/E) ratio of 8.34. Its price-to-book (P/B) ratio is 0.89.
What is the return on equity (ROE) of JRS?
JRS has a return on equity (ROE) of -1.82%.
Is JRS a good stock to buy?
This page provides a data-driven analysis of JRS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.